Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus

References

• Gjødsbøl K, Christensen JJ, Karlsmark T, et al. Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J 2006;3(3):225-31
   PubMedGoogle Scholar
• Serra R, Grande R, Butrico L, et al. Skin grafting and topical application of platelet gel in the treatment of vascular lower extremity ulcers. Acta Phlebol 2014;15(3):129-36
   Google Scholar
• Skerritt L, Moore Z. The prevalence, aetiology and management of wounds in a community care area in Ireland. Br J Community Nurs 2014(Suppl):S11-17
   Google Scholar
• Markova A, Mostow EN. US skin disease assessment: ulcer and wound care. Dermatol Clin 2012;30(1):107-11; ix
   PubMed Web of Science ®Google Scholar
• Gottrup F. A specialized wound-healing center concept: importance of a multidisciplinary department structure and surgical treatment facilities in the treatment of chronic wounds. Am J Surg 2004;187(5A):38S-43S
   PubMed Web of Science ®Google Scholar
• Pannier F, Rabe E. Differential diagnosis of leg ulcers. Phlebology 2013;28(Suppl 1):55-60
   PubMedGoogle Scholar
• Wang T, Feng Y, Sun H, et al. miR-21 regulates skin wound healing by targeting multiple aspects of the healing process. Am J Pathol 2012;181(6):1911-20
   PubMed Web of Science ®Google Scholar
• Johnson KE, Wilgus TA. Vascular endothelial growth factor and angiogenesis in the regulation of cutaneous wound repair. Adv Wound Care (New Rochelle) 2014;3(10):647-61
   PubMedGoogle Scholar
• Serra R, Buffone G, Costanzo G, et al. Altered Metalloproteinase-9 expression as the least common denominator between Varicocele, Inguinal Hernia and Chronic Venous Disorders. Ann Vasc Surg 2014;28(3):705-9
   PubMedGoogle Scholar
• Amato B, Coretti G, Compagna R, et al. Role of matrix metalloproteinases in non-healing venous ulcers. Int Wound J 2013. [Epub ahead of print]
   Web of Science ®Google Scholar
• Serra R, Buffone G, Falcone D, et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin. Wound Repair Regen 2013;21(3):395-401
   PubMed Web of Science ®Google Scholar
• Serra R, Grande R, Buffone G, et al. The effects of minocycline on extracellular matrix in patients with chronic venous leg ulcers. Act Phlebol 2013;14:99-107
   Google Scholar
• Serra R, Grande R, Butrico L, et al. Effects of a new nutraceutical substance on clinical and molecular parameters in patients with chronic venous ulceration. Int Wound J 2014. [Epub ahead of print]
   Web of Science ®Google Scholar
• Serra R, Gallelli L, Buffone G, et al. Doxycycline speeds up healing of chronic venous ulcers. Int Wound J 2013. [Epub ahead of print]
   Web of Science ®Google Scholar
• Serra R, Gallelli L, Conti A, et al. The effects of Sulodexide on both clinical and molecular parameters in patients with mixed arterial and ulcers of lower limbs. Drug Des Devel Ther 2014;8:1-9
   PubMedGoogle Scholar
• Serra R, Grande R, Buffone G, et al. Extracellular matrix assessment of infected chronic venous leg ulcers: role of metalloproteinases and inflammatory cytokines. Int Wound J 2014. [Epub ahead of print]
   Google Scholar
• Kim BK, Lee YK, Park KY, et al. Analysis of multiple risk factors affecting the result of free flap transfer for necrotisingsoft tissue defects of the lower extremities in patients with type 2 diabetes mellitus. J Plast Reconstr Aesthet Surg 2014;67(5):624-8
   PubMedGoogle Scholar
• Wysocki AB, Bhalla-Regev SK, Tierno PMJr, et al. Proteolytic activity by multiple bacterial species isolated from chronic venous leg ulcers degrades matrix substrates. Biol Res Nurs 2013;15(4):407-15
   PubMedGoogle Scholar
• Renner R, Sticherling M, Rüger R, Simon J. Persistence of bacteria like Pseudomonas aeruginosa in non-healing venous ulcers. Eur J Dermatol 2012;22(6):751-7
   PubMedGoogle Scholar
• Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H. T opical silver for preventing wound infection. Cochrane Database Syst Rev 2010(3):CD006478
   Google Scholar
• Nelson EA, O’Meara S, Golder S, DASIDU Steering Group. Systematic review of antimicrobial treatments for diabetic foot ulcers. Diabet Med 2006;23(4):348-59
   PubMed Web of Science ®Google Scholar
• Chow I, Lemos EV, Einarson TR. Management and prevention of diabetic foot ulcers and infections: a health economic review. Pharmacoeconomics 2008;26(12):1019-35
   PubMed Web of Science ®Google Scholar
• Fazli M, Bjarnsholt T, Kirketerp-Møller K, et al. Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic wounds. J Clin Microbiol 2009;47(12):4084-9
   PubMed Web of Science ®Google Scholar
• Malic S, Hill KE, Hayes A, et al. Detection and identification of specific bacteria in wound biofilms using peptide nucleic acid fluorescent in situ hybridization (PNA FISH). Microbiology 2009;155(Pt 8):2603-11
   PubMedGoogle Scholar
• Forster AJ, Oake N, Roth V, et al. Patient-level factors associated with methicillin-resistant Staphylococcus aureus carriage at hospital admission: a systematic review. Am J Infect Control 2013;41(3):214-20
   PubMedGoogle Scholar
• Gilchrist B. Treating bacterial wound infection. Nurs Times 1994;90(50):55-6; 58
   PubMedGoogle Scholar
• Schmidtchen A, Wolff H, Hansson C. Differential proteinase expression by Pseudomonas aeruginosa derived from chronic leg ulcers. Acta Derm Venereol 2001;81(6):406-9
   PubMed Web of Science ®Google Scholar
• Vatcheva-Dobrevska R, Mulet X, Ivanov I, et al. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals. Microb Drug Resist 2013;19(5):355-61
   PubMed Web of Science ®Google Scholar
• De Leon S, Clinton A, Fowler H, et al. Synergistic Interactions of pseudomonas aeruginosa and staphylococcus aureus in an in vitro wound Model. Infect Immun 2014;82(11):4718-28
   PubMedGoogle Scholar
• Pastar I, Nusbaum AG, Gil J, et al. Interactions of Methicillin Resistant Staphylococcus aureus USA300 and Pseudomonas aeruginosa in Polymicrobial Wound Infection. PLoS One 2013;8(2):1-11
   Google Scholar
• Percival SL, Emanuel C, Cutting KF, Williams DW. Microbiology of the skin and the role of biofilms in infection. Int Wound J 2012;9:14-32
   PubMed Web of Science ®Google Scholar
• Christensen GJ, Brüggemann H. Bacterial skin commensals and their role as host guardians. Benef Microbes 2014;5(2):201-15
   PubMed Web of Science ®Google Scholar
• Tuazon CU. Skin and skin structure infections in the patient at risk: carrier state of Staphylococcus aureus. Am J Med 1984;76(5A):166-71
   PubMedGoogle Scholar
• Hannigan GD, Grice EA. Microbial ecology of the skin in the era of metagenomics and molecular microbiology. Cold Spring Harb Perspect Med 2013;3(12):a015362
   Google Scholar
• Nizet V, Ohtake T, Lauth X, et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001;414:454-7
   PubMed Web of Science ®Google Scholar
• Wanke I, Steffen H, Christ C, et al. Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol 2011;131(2):382-90
   PubMed Web of Science ®Google Scholar
• Wang G. Human antimicrobial peptides and proteins. Pharmaceuticals (Basel) 2014;7(5):545-94
   PubMedGoogle Scholar
• Schittek B. The antimicrobial skin barrier in patients with atopic dermatitis. Curr Probl Dermatol 2011;41:54-67
   Google Scholar
• Chaiwarith R, Pacharasupal P, Sirisanthana T. Epidemiology, clinical characteristics and treatment outcomes of healthcare- associated methicillin-resistant Staphylococcus aureus BLOODSTREAM infections at Chiang Mai University Hospital: a retrospective study. Southeast Asian J Trop Med Public Health 2014;45(4):897-905
   PubMedGoogle Scholar
• Truong-Bolduc QC, Villet RA, Estabrooks ZA, Hooper DC. Native efflux pumps contribute resistance to antimicrobials of skin and the ability of Staphylococcus aureus to colonize skin. J Infect Dis 2014;209(9):1485-93
   PubMedGoogle Scholar
• Coates R, Moran J, Horsburgh MJ. Staphylococci: colonizers and pathogens of human skin. Future Microbiol 2014;9(1):75-91
   PubMed Web of Science ®Google Scholar
• Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen 2003;11:S1-28
   Web of Science ®Google Scholar
• Fedtke I, Gotz F, Peschel A. Bacterial evasion of innate host defences: the Staphylococcus aureus lesson. Int J Med Microbiol 2004;294:189-94
   PubMed Web of Science ®Google Scholar
• Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998;339(8):520-32
   PubMed Web of Science ®Google Scholar
• Daum RS, Spellberg B. Progress toward a staphylococcus aureus vaccine. Clin Infect Dis 2012;54(4):560-7
   PubMed Web of Science ®Google Scholar
• Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol 2005;3:948-58
   PubMed Web of Science ®Google Scholar
• Jensen PØ, Bjarnsholt T, Phipps R, et al. Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum sensing controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiology 2007;153:1329-38
   PubMed Web of Science ®Google Scholar
• Amin AN, Cerceo EA, Deitelzweig SB, et al. Hospitalist perspective on the treatment of skin and soft tissue infections. Mayo Clin Proc 2014;89(10):1436-51
   PubMed Web of Science ®Google Scholar
• Costerton JW, Lewandowski Z, Caldwell DE, et al. Microbial biofilms. Annu Rev Microbiol 1995;49:711-45
   PubMed Web of Science ®Google Scholar
• Matsukawa M, Greenberg EP. Putative exopolysaccharide synthesis genes influence Pseudomonas aeruginosa biofilm development. J Bacteriol 2004;186:4449-56
   PubMed Web of Science ®Google Scholar
• Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS. Extracellular DNA required for bacterial biofilm formation. Science 2002;295:1487
   PubMed Web of Science ®Google Scholar
• Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003;9:978-84
   PubMed Web of Science ®Google Scholar
• Finck-Barbançon V, Duportail G, Meunier O, Colin DA. Pore formation by a two-component leukocidin from Staphylococcus aureus within the membrane of human polymorphonuclear leukocytes. Biochim Biophys Acta 1993;1182(3):275-82
   PubMedGoogle Scholar
• Staali L, Monteil H, Colin DA. The staphylococcal pore-forming leukotoxins open Ca2+ channels in the membrane of human polymorphonuclear neutrophils. J Membr Biol 1998;162(3):209-16
   PubMedGoogle Scholar
• Hammer C, Rath PM, Steinmann J, et al. Panton-Valentine leukocidin in patients with chronic wounds. Results from a clinical investigation in 100 patients. Hautarzt 2014;65(2):148-52
   PubMedGoogle Scholar
• Berktold M, Grif K, Mäser M, et al. Genetic characterization of Panton-Valentine leukocidin-producing methicillin-resistant Staphylococcus aureus in Western Austria. Wien Klin Wochenschr 2012;124(19-20):709-15
   PubMedGoogle Scholar
• Witte W, Strommenger B, Cuny C, et al. Methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leucocidin gene in Germany in 2005 and 2006. J Antimicrob Chemother 2007;60(6):1258-63
   PubMedGoogle Scholar
• Wilson M, Seymour R, Henderson B. Bacterial perturbation of cytokine networks. Infect Immun 1998;66:2401
   PubMed Web of Science ®Google Scholar
• Wolcott RD, Rhoads DD. A study of biofilm-based wound management in subjects with critical limb ischaemia. J Wound Care 2008;17(4):145-8; 150-2, 154-5
   PubMedGoogle Scholar
• Wolcott R, Costerton JW, Raoult D, Cutler SJ. The polymicrobial nature of biofilm infection. Clin Microbiol Infect 2013;19(2):107-12
   PubMed Web of Science ®Google Scholar
• Halbert AR, Stacey MC, Rohr JB, Jopp-McKay A. The effect of bacterial colonization on venous ulcer healing. Australas J Dermatol 1992;33:75-80
   PubMedGoogle Scholar
• Madsen SM, Westh H, Danielsen L, Rosdahl VT. Bacterial colonization and healing of venous leg ulcers. APMIS 1996;104:895-9
   PubMed Web of Science ®Google Scholar
• Høiby N, Bjarnsholt T, Moser C, ESCMID Study Group for Biofilms (ESGB) and Consulting External Expert Werner Zimmerli. ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. Clin Microbiol Infect 2015. [Epub ahead of print]
   Google Scholar
• Dowd SE, Wolcott RD, Sun Y, et al. Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS One 2008;3(10):e3326
   PubMed Web of Science ®Google Scholar
• Baffoni M, Bessa LJ, Grande R, et al. Laser irradiation effect on Staphylococcus aureus and Pseudomonas aeruginosa biofilms isolated from venous leg ulcer. Int Wound J 2012;9(5):517-24
   PubMedGoogle Scholar
• Ammons MC, Copié V. Mini-review: lactoferrin: a bioinspired, anti-biofilm therapeutic. Biofouling 2013;29(4):443-55
   PubMed Web of Science ®Google Scholar
• Haji Zaine N, Burns J, Vicaretti M, et al. Characteristics of diabetic foot ulcers in Western Sydney, Australia. J Foot Ankle Res 2014;7(1):39
   PubMedGoogle Scholar
• Arya AK, Tripathi R, Kumar S, Tripathi K. Recent advances on the association of apoptosis in chronic non healing diabetic wound. World J Diabetes 2014;5(6):756-62
   PubMedGoogle Scholar
• Jenkins TC, Knepper BC, Jason Moore S, et al. Comparison of the microbiology and antibiotic treatment among diabetic and nondiabetic patients hospitalized for cellulitis or cutaneous abscess. J Hosp Med 2014;9(12):788-94
   PubMedGoogle Scholar
• Nguyen KT, Seth AK, Hong SJ, et al. Deficient cytokine expression and neutrophil oxidative burst contribute to impaired cutaneous wound healing in diabetic biofilm-containing chronic wounds. Wound Repair Regen 2013;21(6):833-41
   PubMed Web of Science ®Google Scholar
• Oyibo SO, Jude EB, Tarawneh I, et al. The effects of ulcer size and site, patient’s age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med 2001;18(2):133-8
   PubMed Web of Science ®Google Scholar
• Ammons MC. Anti-biofilm strategies and the need for innovations in wound care. Recent Pat Antiinfect Drug Discov 2010;5(1):10-17
   PubMedGoogle Scholar
• Percival SL, Hill KE, Williams DW, et al. A review of the scientific evidence for biofilms in wounds. Wound Repair Regen 2012;20(5):647-57
   PubMed Web of Science ®Google Scholar
• Malik A, Mohammad Z, Ahmad J. The diabetic foot infections: biofilms and antimicrobial resistance. Diabetes Metab Syndr 2013;7(2):101-7
   PubMedGoogle Scholar
• Percival SL, Hill KE, Malic S, et al. Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilms. Wound Repair Regen 2011;19(1):1-9
   PubMed Web of Science ®Google Scholar
• Bjarnsholt T, Kirketerp-Møller K, Jensen PØ, et al. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 2008;16(1):2-10
   PubMed Web of Science ®Google Scholar
• Watters C, DeLeon K, Trivedi U, et al. Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice. Med Microbiol Immunol 2013;202(2):131-41
   PubMed Web of Science ®Google Scholar
• Ortiz Balbuena J, García Madero R, Segovia Gómez T, et al. Microbiology of pressure and vascular ulcer infections. Rev Esp Geriatr Gerontol 2015;50(1):5-8
   PubMedGoogle Scholar
• Hansson C, Hoborn J, Möller A, Swanbeck G. The microbial flora in venous leg ulcers without clinical signs of infection. Repeated culture using a validated standardised microbiological technique. Acta Derm Venereol 1995;75(1):24-30
   PubMed Web of Science ®Google Scholar
• Lantis JCII, Gendics C. In vivo effect of sustained-release silver sulphadiazine foam on bioburden and wound closure in infected venous leg ulcers. J Wound Care 2011;20(2):90-6
   PubMedGoogle Scholar
• O’Meara S, Al-Kurdi D, Ologun Y, et al. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 2014;1:CD003557
   Google Scholar
• Serra R, Caroleo S, Buffone G, et al. Low serum albumin level as an independent risk factor for the onset of pressure ulcers in intensive care unit patients. Int Wound J 2014;11(5):550-3
   PubMedGoogle Scholar
• Serra R, Grande R, Buffone G, et al. Albumin administration prevents the onset of pressure ulcers in intensive care unit patients. Int Wound J 2013. [Epub ahead of print]
   Google Scholar
• Stotts NA, Hunt TK. Pressure ulcers. Managing bacterial colonization and infection. Clin Geriatr Med 1997;13(3):565-73
   PubMedGoogle Scholar
• Lindholm C. Pressure ulcers and infection – understanding clinical features. Ostomy Wound Manage 2003;49(5A Suppl):4-7
   PubMedGoogle Scholar
• Gist S, Tio-Matos I, Falzgraf S, et al. Wound care in the geriatric client. Clin Interv Aging 2009;4:269-87
   PubMed Web of Science ®Google Scholar
• Braga IA, Pirett CC, Ribas RM, et al. Bacterial colonization of pressure ulcers: assessment of risk for bloodstream infection and impact on patient outcomes. J Hosp Infect 2013;83(4):314-20
   PubMed Web of Science ®Google Scholar
• Gandra S, Barysauskas CM, Mack DA, et al. Impact of contact precautions on falls, pressure ulcers and transmission of MRSA and VRE in hospitalized patients. J Hosp Infect 2014;88(3):170-6
   PubMedGoogle Scholar
• Miyoshi S, Shinoda S. Microbial metalloproteases and pathogenesis. Microbes Infect 2000;2:91-8
   PubMed Web of Science ®Google Scholar
• Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006;69(3):562-73
   PubMed Web of Science ®Google Scholar
• Geurts N, Opdenakker G, Van den Steen PE. Matrix metalloproteinases as therapeutic targets in protozoan parasitic infections. Pharmacol Ther 2012;133:257-9
   PubMed Web of Science ®Google Scholar
• Flores-Herrera H, Garcıa-Lopez G, D´ıaz NF, et al. An experimental mixed bacterial infection induced differential secretion of proinflammatory cytokines (IL-1beta, TNFalpha) and proMMP-9 in human fetal membranes. Placenta 2012;33:271-7
   PubMedGoogle Scholar
• Grayfer L, Hodgkinson JW, Belosevic M. Antimicrobial responses of teleost phagocytes and innate immune evasion strategies of intracellular bacteria. Dev Comp Immunol 2014;43:223-42
   PubMedGoogle Scholar
• Maeda H. Role of microbial proteases in pathogenesis. Microbiol Immunol 1996;40(10):685-99
   PubMedGoogle Scholar
• Maeda H, Akaike T, Sakata Y, Maruo K. Role of bradykinin in microbial infection: enhancement of septicemia by microbial proteases and kinin. Agents Actions Suppl 1993;42:159-65
   PubMedGoogle Scholar
• Maeda H, Yamamoto T. Pathogenic mechanisms induced by microbial proteases in microbial infections. Biol Chem Hoppe Seyler 1996;377(4):217-26
   PubMedGoogle Scholar
• Golovkine G, Faudry E, Bouillot S, et al. VE-cadherin cleavage by LasB protease from Pseudomonas aeruginosa facilitates type III secretion system toxicity in endothelial cells. PLoS Pathog 2014;10(3):e1003939
   Google Scholar
• Beaufort N, Corvazier E, Mlanaoindrou S, et al. Disruption of the endothelial barrier by proteases from the bacterial pathogen Pseudomonas aeruginosa: implication of matrilysis and receptor cleavage. PLoS One 2013;8(9):e75708
   Google Scholar
• Cheng AG, De Dent AC, Schneewind O, Missiakas D. A play in four acts: staphylococcus aureus abscess formation. Trends Microbiol 2011;19(5):225-32
   PubMed Web of Science ®Google Scholar
• Nishifuji K, Sugai M, Amagai M. Staphylococcal exfoliative toxins: “molecular scissors” of bacteria that attack the cutaneous defense barrier in mammals. J Dermatol Sci 2008;49(1):21-31
   PubMed Web of Science ®Google Scholar
• Kim HK, Missiakas D, Schneewind O. Mouse models for infectious diseases caused by Staphylococcus aureus. J Immunol Methods 2014;410:88-99
   PubMed Web of Science ®Google Scholar
• Ladhani S. Understanding the mechanism of action of the exfoliative toxins of Staphylococcus aureus. FEMS Immunol Med Microbiol 2003;39(2):181-9
   PubMedGoogle Scholar
• Wilke GA, Bubeck Wardenburg J. Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury. Proc Natl Acad Sci USA 2010;107(30):13473-8
   PubMed Web of Science ®Google Scholar
• Inoshima I, Inoshima N, Wilke GA, et al. A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nat Med 2011;17(10):1310-14
   PubMed Web of Science ®Google Scholar
• Inoshima N, Wang Y, Bubeck Wardenburg J. Genetic requirement for ADAM10 in severe Staphylococcus aureus skin infection. J Invest Dermatol 2012;132(5):1513-16
   PubMed Web of Science ®Google Scholar
• Davies CE, Hill KE, Wilson MJ, et al. Use of 16S ribosomal DNA PCR and denaturing gradient gel electrophoresis for analysis of the microfloras of healing and nonhealing chronic venous leg ulcers. J Clin Microbiol 2004;42(8):3549-57
   PubMed Web of Science ®Google Scholar
• James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen 2008;16(1):37-44
   PubMed Web of Science ®Google Scholar
• Kirketerp-Møller K, Jensen PØ, Fazli M, et al. Distribution, organization, and ecology of bacteria in chronic wounds. J Clin Microbiol 2008;46(8):2717-22
   PubMed Web of Science ®Google Scholar
• Gurusamy KS, Koti R, Toon CD, et al. Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in non surgical wounds. Cochrane Database Syst Rev 2013;11:CD010427
   Google Scholar
• Harkless L, Boghossian J, Pollak R, et al. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers. Surg Infect (Larchmt) 2005;6(1):27-40
   PubMedGoogle Scholar
• Körber A, Schmid EN, Buer J, et al. Bacterial colonization of chronic leg ulcers: current results compared with data 5 years ago in a specialized dermatology department. J Eur Acad Dermatol Venereol 2010;24(9):1017-25
   PubMedGoogle Scholar
• Bessa LJ, Fazii P, Di Giulio M, Cellini L. Bacterial isolates from infected wounds and their antibiotic susceptibility pattern: some remarks about wound infection. Int Wound J 2013;12(1):47-52
   PubMedGoogle Scholar
• Jacobsen F, Fisahn C, Sorkin M, et al. Efficacy of topically delivered moxifloxacin against wound infection by pseudomonas aeruginosa and methicillin-resistant staphylococcus aureus [down-pointing small open triangle]. Antimicrob Agents Chemother 2011;55(5):2325-34
   PubMed Web of Science ®Google Scholar
• Nathwani D, Raman G, Sulham K, et al. Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrob Resist Infect Control 2014;3(1):32
   PubMed Web of Science ®Google Scholar
• Gallelli L, Ferreri G, Colosimo M, et al. Adverse drug reactions to antibiotics observed in two pulmonology divisions of Catanzaro, Italy: a six-year retrospective study. Pharmacol Res 2002;46(5):395-400
   PubMedGoogle Scholar
• Palleria C, Di Paolo A, Giofrè C, et al. Pharmacokinetic drug-drug interaction and their implication in clinical management. J Res Med Sci 2013;18(7):601-10
   PubMed Web of Science ®Google Scholar
• Kim J, Ohtani H, Tsujimoto M, Sawada Y. Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents. Drug Metab Pharmacokinet 2009;24(2):167-74
   PubMedGoogle Scholar
• van der Linden PD, Sturkenboom MC, Herings RM, et al. Fluoroquinolones and risk of Achilles tendon disorders: case-control study. BMJ 2002;324(7349):1306-7
   PubMed Web of Science ®Google Scholar
• Falagas ME, Rafailidis PI, Rosmarakis ES. Arrhythmias associated with fluoroquinolone therapy. Int J Antimicrob Agents 2007;29(4):374-9
   PubMedGoogle Scholar
• Nykamp DL, Blackmon CL, Schmidt PE, Roberson AG. QTc prolongation associated with combination therapy of levofloxacin, imipramine, and fluoxetine. Ann Pharmacother 2005;39(3):543-6
   PubMed Web of Science ®Google Scholar
• Siniscalchi A, Scaglione F, Sanzaro E, et al. Effects of phenobarbital and levetiracetam on PR and QTc intervals in patients with post-stroke seizure. Clin Drug Investig 2014;34(12):879-86
   PubMed Web of Science ®Google Scholar
• Ni W, Cai X, Liang B, et al. Effect of proton pump inhibitors on in vitro activity of tigecycline against several common clinical pathogens. PLoS One 2014;9(1):e86715
   Google Scholar
• Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014;59(2):e10-52
   PubMed Web of Science ®Google Scholar
• Deresinski S. Counterpoint: vancomycin Staphylococcus aureus–an antibiotic enters obsolescence. Clin Infect Dis 2007;44:1543-8
   PubMed Web of Science ®Google Scholar
• Kollef MH. Limitations of vancomycin in the management of resistant staphylococcal infections. Clin Infect Dis 2007;45(Suppl 3):S191-5
   PubMed Web of Science ®Google Scholar
• Sakoulas G, Moise-Broder PA, Schentag J, et al. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004;42:2398-402
   PubMed Web of Science ®Google Scholar
• Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011;52(3):285-92
   PubMed Web of Science ®Google Scholar
• Boucher HW, Sakoulas G. Perspectives on daptomycin resistance, with emphasis on resistance in Staphylococcus aureus. Clin Infect Dis 2007;45:601-8
   PubMed Web of Science ®Google Scholar